ExPeCT Expansion & Persistence of CAR T Build info
Synonyms |
|
||||||||||||
Short Name |
EXPECT EXPANSION & PERSISTENCE OF CAR T |
||||||||||||
Procedure Master Number |
LAB4149 |
||||||||||||
Procedure ID |
|||||||||||||
Clinical Info |
For Hematology/Oncology patients this assay provides interventional data which may provide information on the expansion and persistence of the genetically modified T-cells used as therapeutic treatment for specific lymphomas and leukemias (Chimeric Antigen Receptor T-cell therapy or CAR T). However, some patients fail CAR-T therapy due to lack of cell expansion or persistence. Eurofins Viracor has developed and validated a multiplexed quantitative real-time PCR (qPCR) assay targeting the single chain variable fragment (scFv) FMC63 for the longitudinal monitoring of CD19-directed CAR T-cell therapy. |
||||||||||||
Specimen Sources |
Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous | ||||||||||||
Specimen Types |
Blood | ||||||||||||
Container |
Lavender top Tube |
||||||||||||
Collection Instructions |
Container/Tube: Lavender Top Tube |
||||||||||||
Transport Instructions |
Room Temperature |
||||||||||||
Specimen Stability |
7 Days Room Temperature |
||||||||||||
Methodology |
Real-Time PCR |
||||||||||||
Days Performed |
TAT: 2 - 4 Days |
||||||||||||
Performing Laboratory |
Viracor-Eurofins |
||||||||||||
CPT |
80299 |
||||||||||||
PDM |
245309 | ||||||||||||
Only Orderable at Locations: |
Orderable Everywhere | ||||||||||||
Results |
|